Skip to content
Saturday, January 28, 2023
Latest:
  • Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
  • Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay
  • Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run
  • Eisai Awarded The New Diversity Management Selection 100
  • MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company
Biotech Trends Report

Biotech Trends Report

Know First, Act First

  • New Drugs & Trials
  • General
  • Leaders
  • Technology
  • Global
  • Trending

New Drugs & Trials

BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

Read more
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa

Canada NewsWire VICTORIA, BC, Nov. 19, 2020 VICTORIA, BC, Nov. 19, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV:

Read more
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures  Nutra Pharma is providing updates on their work in

Read more
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa

SAN FRANCISCO, Dec. 7, 2020/CNW/ — PostEra, a biotechnology company specializing in machine learning solutions for preclinical drug discovery, today

Read more
BIOTCHNO New Drugs & Trials 

Haoma Medica Completes First-in-Human Trial for NaQuinate, a Novel Treatment in Development for Osteoporosis

October 26, 2020April 15, 2021 vanessa

Canada NewsWire LONDON, Nov. 26, 2020 LONDON, Nov. 26, 2020/CNW/ — Haoma Medica announced today the completion of a first-in-human trial

Read more

New Drugs & Trials

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant
BIOTCHNO New Drugs & Trials 

Mountain Valley MD Files Patent for Novel Vaccine Dose Sparing Adjuvant

January 20, 2021April 13, 2021 vanessa

Canada NewsWire MVMD immediately proceeding with selection of Contract Research Organization to conduct adjuvant IPV studyTORONTO,Jan. 20, 2021/CNW/ –Mountain Valley

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
BIOTCHNO New Drugs & Trials 

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease

November 19, 2020April 14, 2021 vanessa
Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures
BIOTCHNO New Drugs & Trials 

Nutra Pharma Provides Updates on Progress of their Nerve Agent Countermeasures

November 18, 2020April 8, 2021 vanessa
PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery
BIOTCHNO New Drugs & Trials 

PostEra enters a multi-year strategic partnership with Pfizer Inc. to advance machine learning for Drug Discovery

November 7, 2020April 15, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057